Lactobacillus fermentum SBS-1 and Reduced Intestinal Inflammation

• Microbial-Derived Antioxidants in Intestinal Inflammation: A Systematic Review of Their Therapeutic Potential.

  • 2025-03-06
  • Review
  • Antioxidants (Basel, Switzerland) 14(3)
  • • María José García Mansilla
    • María Jesús Rodríguez Sojo
    • Andreea Roxana Lista
    • Ciskey Vanessa Ayala Mosqueda
    • Antonio Jesús Ruiz Malagón
    • Ailec Ho Plagaro
    • Julio Gálvez
    • Alba Rodríguez Nogales
    • María José Rodríguez Sánchez

  • PubMed: 40227262
  • DOI: 10.3390/antiox14030321

  1 Insight on

  • Reduced Intestinal Inflammation

  • Low evidence

  Certain compounds, such as exopolysaccharides (EPS) and short-chain fatty acids (SCFAs), which have demonstrated their ability to neutralize ROS and strengthen the integrity of the intestinal barrier, thereby attenuating inflammatory responses.

  Effect

  Beneficial

  Effect size

  Moderate